SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,949,806 | +4.6% | 552,300 | -1.2% | 0.75% | +5.8% |
| Q2 2023 | $64,005,228 | +944.0% | 558,900 | +1156.5% | 0.71% | +648.4% |
| Q1 2023 | $6,130,541 | +147.8% | 44,479 | +133.0% | 0.10% | +120.9% |
| Q4 2022 | $2,473,682 | -4.9% | 19,090 | -18.9% | 0.04% | -10.4% |
| Q3 2022 | $2,602,000 | -69.5% | 23,539 | -79.3% | 0.05% | -66.4% |
| Q2 2022 | $8,520,000 | +76.6% | 113,660 | +84.0% | 0.14% | +155.4% |
| Q1 2022 | $4,825,000 | +935.4% | 61,759 | +929.8% | 0.06% | +700.0% |
| Q2 2021 | $466,000 | -94.7% | 5,997 | -88.5% | 0.01% | -94.9% |
| Q4 2020 | $8,863,000 | +201.3% | 51,986 | +168.5% | 0.14% | +29.0% |
| Q2 2019 | $2,942,000 | -7.3% | 19,359 | -27.3% | 0.11% | -34.0% |
| Q1 2019 | $3,174,000 | -47.2% | 26,626 | -28.5% | 0.16% | -57.6% |
| Q3 2018 | $6,011,000 | -53.2% | 37,216 | -61.7% | 0.38% | -42.6% |
| Q2 2018 | $12,841,000 | – | 97,145 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |